Around age 45, about 90% of people will start to notice their near vision declining. This condition that forces adults to hold their menus out further, or remember their reading glasses is called Presbyopia. According to the American Optometric Association approximately 128 million Americans are affected by this change in vision. VIZZ is the first and only U.S.-approved once-daily eye drop specifically indicated for adults with Presbyopia. Up until now, reading glasses or multifocal lenses have been the standard, but VIZZ introduces a pharmacologic option: one drop in each eye daily that improves near vision for many users.

Here are some of the FAQs about the prescription eye drop.

1. What is VIZZ used for?

VIZZ is a prescription eye drop indicated for adults with age-related blurry near vision (presbyopia).

2. How does VIZZ work?

The active ingredient, aceclidine, is a “pupil-selective miotic” that constricts the iris sphincter muscle, reducing pupil diameter to about 2 mm or less (a “pinhole effect”). This increases depth of focus, thereby improving near vision without a strong effect on the ciliary muscle.

3. How quickly does it work and how long does the effect last?

In clinical studies, near-vision improvement was observed within about 30 minutes. The effect has been shown to last up to about 10 hours in many patients.

4. What is the VIZZ dosage?

Most doctors will prescribe one drop in each eye once daily, however some doctors may prescribe a second drop after 2 minutes. It is important to get a full exam and consultation with your eye doctor to determine what is right for you.

5. What are the common side-effects?

The most frequently reported adverse reactions include eye irritation (~20 %), dim or dark vision (~16 %), and headache (~13 %). Others (>5 %) include conjunctival hyperemia (~8 %) and ocular hyperemia (~7 %).

6. What are important safety or usage warnings?

  • Remove contact lenses before using. Lenses may be reinserted about 10 minutes after dosing.
  • Patients may experience temporary dim or dark vision and should not drive or operate machinery until vision is clear.
  • There’s a risk of retinal tear or detachment with miotics in susceptible individuals—retinal exam may be advised.
  • If using other ophthalmic drops, separate by at least 5 minutes.

7. Who is a good candidate?

Adults with presbyopia who are seeking a non-glasses option (or supplement to glasses) for near-vision improvement may be candidates. However, candidacy should be determined by your eye doctor, considering ocular health (e.g., retina, angle status).

8. Will it replace reading glasses entirely?

Not necessarily. While VIZZ offers a daily drop alternative and may reduce or replace the need for reading glasses for near tasks during its effect window, it may not fully replace glasses in all situations (depending on individual vision needs, lighting, other eye conditions).